SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Nordex SE (NRDXF) trades at a trailing P/E of 45.9, forward P/E of 29.1. Trailing earnings yield is 2.18%, forward earnings yield 3.43%. PEG 0.02 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (15/100, Fail) — trailing P/E is well above the S&P 500 average of ~25, suggesting a premium valuation (P/E 45.9).
- Forward P/E 29.1 (down from trailing 45.9) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.02 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 2.18% — below bond yields — investors are paying a premium for expected growth rather than current earnings. Forward yield improves to 3.43% as earnings recover.
Overall SharesGrow Score: 51/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
15/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — NRDXF
Valuation Multiples
P/E (TTM)45.9
Forward P/E29.1
PEG Ratio0.02
Forward PEG0.51
P/B Ratio0.00
P/S Ratio1.67
EV/EBITDA0.0
Per Share Data
EPS (TTM)$1.16
Forward EPS (Est.)$1.83
Book Value / Share$0.00
Revenue / Share$31.93
FCF / Share$0.00
Yields & Fair Value
Earnings Yield2.18%
Forward Earnings Yield3.43%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.90 |
$3.4B |
$95.35M |
2.8% |
| 2017 |
$0.00 |
$3.08B |
$329K |
0% |
| 2018 |
$-0.76 |
$2.46B |
$-83.85M |
-3.4% |
| 2019 |
$-0.64 |
$3.28B |
$-72.57M |
-2.2% |
| 2020 |
$-1.05 |
$4.65B |
$-129.71M |
-2.8% |
| 2021 |
$-1.56 |
$5.44B |
$-230.16M |
-4.2% |
| 2022 |
$-2.71 |
$5.69B |
$-497.76M |
-8.7% |
| 2023 |
$-1.33 |
$6.49B |
$-302.83M |
-4.7% |
| 2024 |
$0.04 |
$7.3B |
$8.84M |
0.1% |
| 2025 |
$1.16 |
$7.55B |
$274.2M |
3.6% |
